MFCAX
Price
$39.71
Change
-$0.20 (-0.50%)
Updated
Aug 7 closing price
Net Assets
577.09M
NAESX
Price
$115.17
Change
-$0.19 (-0.16%)
Updated
Aug 7 closing price
Net Assets
154.18B
Interact to see
Advertisement

MFCAX vs NAESX

Header iconMFCAX vs NAESX Comparison
Open Charts MFCAX vs NAESXBanner chart's image
Meridian Contrarian A
Price$39.71
Change-$0.20 (-0.50%)
VolumeN/A
Net Assets577.09M
Vanguard Small Cap Index I
Price$115.17
Change-$0.19 (-0.16%)
VolumeN/A
Net Assets154.18B
MFCAX vs NAESX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MFCAX vs. NAESX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFCAX is a StrongBuy and NAESX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 154B vs. MFCAX (577M). NAESX pays higher dividends than MFCAX: NAESX (1.25) vs MFCAX (0.21). MFCAX was incepted earlier than NAESX: MFCAX (12 years) vs NAESX (65 years). MFCAX (1.45) is less costly to investors than NAESX (0.17). MFCAX is a more actively managed with annual turnover of: 58.00 vs. NAESX (13.00). MFCAX has a lower initial minimum investment than NAESX: MFCAX (2500) vs NAESX (3000). MFCAX annual gain was more profitable for investors over the last year : 16.53 vs. NAESX (12.34). NAESX return over 5 years is better than : 54.62 vs. MFCAX (21.47).
MFCAXNAESXMFCAX / NAESX
Total Expense Ratio1.450.17853%
Annual Report Gross Expense Ratio1.450.17853%
Fund Existence12 years65 years-
Gain YTD8.6580.3372,573%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets577M154B0%
Annual Yield % from dividends0.211.2517%
Returns for 1 year16.5312.34134%
Returns for 3 years3.3322.7215%
Returns for 5 years21.4754.6239%
Returns for 10 years4.76107.614%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP1.830.09
+5.17%
GT Biopharma
KNSA33.110.39
+1.19%
Kiniksa Pharmaceuticals International plc
CRL149.78-0.55
-0.37%
Charles River Laboratories International
EBMT15.74-0.11
-0.69%
Eagle Bancorp Montana
EB2.21-0.25
-10.16%
Eventbrite